10 20 30 40 50 60 70 80 3PSR - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric Unit
HEADER EF-HAND PROTEIN 17-SEP-98 3PSR
TITLE HUMAN PSORIASIN (S100A7) CA2+ BOUND FORM (CRYSTAL FORM I)
COMPND MOL_ID: 1; COMPND 2 MOLECULE: PSORIASIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: S100A7; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: CHAIN A IS CA2+ AND ZN2+ BOUND FORM, CHAIN COMPND 7 B IS CA2+ BOUND FORM
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL: KERATINOCYTES; SOURCE 6 CELLULAR_LOCATION: CYTOPLASMIC, OR MAY BE SECRETED BY A SOURCE 7 NON-CLASSICAL SECRETORY PATHWAY; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 10 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PT7H6FX-PS.4
KEYWDS CA-BINDING, PSORIASIS, S100 PROTEIN FAMILY, X-RAY KEYWDS 2 CRYSTALLOGRAPHY, EF-HAND PROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR D.E.BRODERSEN,J.NYBORG,M.KJELDGAARD
REVDAT 3 24-FEB-09 3PSR 1 VERSN REVDAT 2 01-APR-03 3PSR 1 JRNL REVDAT 1 15-JUN-99 3PSR 0
JRNL AUTH D.E.BRODERSEN,J.NYBORG,M.KJELDGAARD JRNL TITL ZINC-BINDING SITE OF AN S100 PROTEIN REVEALED. TWO JRNL TITL 2 CRYSTAL STRUCTURES OF CA2+-BOUND HUMAN PSORIASIN JRNL TITL 3 (S100A7) IN THE ZN2+-LOADED AND ZN2+-FREE STATES. JRNL REF BIOCHEMISTRY V. 38 1695 1999 JRNL REFN ISSN 0006-2960 JRNL PMID 10026247 JRNL DOI 10.1021/BI982483D
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.E.BRODERSEN,M.ETZERODT,P.MADSEN,J.E.CELIS, REMARK 1 AUTH 2 H.C.THOGERSEN,J.NYBORG,M.KJELDGAARD REMARK 1 TITL EF-HANDS AT ATOMIC RESOLUTION: THE STRUCTURE OF REMARK 1 TITL 2 HUMAN PSORIASIN (S100A7) SOLVED BY MAD PHASING REMARK 1 REF STRUCTURE V. 6 477 1998 REMARK 1 REFN ISSN 0969-2126 REMARK 1 REFERENCE 2 REMARK 1 AUTH S.NOLSOE,S.THIRUP,M.ETZERODT,H.C.THOGERSEN,J.NYBORG REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY DIFFRACTION REMARK 1 TITL 2 STUDIES OF PSORIASIN REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 53 119 1997 REMARK 1 REFN ISSN 0907-4449 REMARK 1 REFERENCE 3 REMARK 1 AUTH P.MADSEN,H.H.RASMUSSEN,H.LEFFERS,B.HONORE, REMARK 1 AUTH 2 K.DEJGAARD,E.OLSEN,J.KIIL,E.WALBUM,A.H.ANDERSEN, REMARK 1 AUTH 3 B.BASSE,J.B.LAURIDSEN,G.P.RATZ,A.CELIS, REMARK 1 AUTH 4 J.VANDEKERCKHOVE,J.E.CELIS REMARK 1 TITL MOLECULAR CLONING, OCCURRENCE, AND EXPRESSION OF A REMARK 1 TITL 2 NOVEL PARTIALLY SECRETED PROTEIN "PSORIASIN" THAT REMARK 1 TITL 3 IS HIGHLY UP-REGULATED IN PSORIATIC SKIN REMARK 1 REF J.INVEST.DERMATOL. V. 97 701 1991 REMARK 1 REFN ISSN 0022-202X
REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 100.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 52.0 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.223 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.220 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.295 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 415 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 8172 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.188 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.184 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.600 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 338 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 6343 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1538 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 3 REMARK 3 SOLVENT ATOMS : 70 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 1610.30 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 0.00 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 0 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 6450 REMARK 3 NUMBER OF RESTRAINTS : 8061 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.004 REMARK 3 ANGLE DISTANCES (A) : 0.015 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.038 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.245 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.029 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.024 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.017 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.066 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL. 91(1973) 201-228 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 3PSR COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 7.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS II REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8199 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 34.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 5.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.12200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 5.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.54400 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: SHELXL-97 REMARK 200 STARTING MODEL: 1PSR REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.7
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.07500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.19000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.33500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 38.19000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.07500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.33500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10210 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -59.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 FOR THIS STRUCTURE, ONLY ONE OF THE TWO ZINC BINDING SITES REMARK 400 ACTUALLY BINDS ZINC (MONOMER A), WHEREAS THE OTHER REMARK 400 (MONOMER B) DOES NOT. ONLY ONE ZINC SITE IS LISTED ON REMARK 400 SITE RECORDS BELOW.
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 97 REMARK 465 GLY A 98 REMARK 465 SER A 99 REMARK 465 GLN A 100 REMARK 465 GLY B 97 REMARK 465 GLY B 98 REMARK 465 SER B 99 REMARK 465 GLN B 100
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 21 CD - NE - CZ ANGL. DEV. = 9.7 DEGREES REMARK 500 ARG B 21 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 92 157.38 -38.22 REMARK 500 CYS A 95 79.52 50.35 REMARK 500 ARG B 21 -138.31 56.91 REMARK 500 ASP B 23 -158.59 -112.01 REMARK 500 ALA B 92 159.21 -29.52 REMARK 500 CYS B 95 76.75 48.24 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 233 DISTANCE = 6.20 ANGSTROMS
REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 102 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 62 OD1 REMARK 620 2 ASN A 64 OD1 84.2 REMARK 620 3 ASP A 66 OD1 85.2 85.8 REMARK 620 4 LYS A 68 O 90.4 163.8 78.4 REMARK 620 5 GLU A 73 OE1 115.8 120.8 146.1 75.4 REMARK 620 6 GLU A 73 OE2 91.5 73.5 159.3 122.1 52.4 REMARK 620 7 HOH A 269 O 172.1 88.5 91.3 95.9 70.7 89.3 REMARK 620 8 ASP A 66 OD2 123.4 77.3 41.0 93.2 119.7 131.3 51.6 REMARK 620 N 1 2 3 4 5 6 7 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 103 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 17 NE2 REMARK 620 2 ASP A 24 OD1 97.7 REMARK 620 3 ASP A 24 OD2 160.0 63.1 REMARK 620 4 HIS B 86 NE2 112.9 135.2 81.0 REMARK 620 5 HIS B 90 NE2 105.5 111.3 87.7 91.8 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA B 102 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP B 62 OD1 REMARK 620 2 ASN B 64 OD1 86.4 REMARK 620 3 ASP B 66 OD1 90.6 89.9 REMARK 620 4 LYS B 68 O 92.9 167.3 77.4 REMARK 620 5 GLU B 73 OE1 116.4 119.4 139.7 72.2 REMARK 620 6 GLU B 73 OE2 92.0 75.2 164.7 117.5 50.5 REMARK 620 7 HOH B 270 O 173.8 87.4 89.0 93.1 67.2 86.7 REMARK 620 8 ASP B 66 OD2 128.9 78.9 41.4 91.8 113.4 129.5 49.2 REMARK 620 N 1 2 3 4 5 6 7
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CAA REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: REGULATORY CA2+ BINDING SITE REMARK 800 SITE_IDENTIFIER: CAB REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: REGULATORY CA2+ BINDING SITE REMARK 800 SITE_IDENTIFIER: ZNA REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: ZN2+ BINDING SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 102 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 103 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 102
DBREF 3PSR A 1 100 UNP P31151 S10A7_HUMAN 1 100 DBREF 3PSR B 1 100 UNP P31151 S10A7_HUMAN 1 100
SEQRES 1 A 100 SER ASN THR GLN ALA GLU ARG SER ILE ILE GLY MET ILE SEQRES 2 A 100 ASP MET PHE HIS LYS TYR THR ARG ARG ASP ASP LYS ILE SEQRES 3 A 100 ASP LYS PRO SER LEU LEU THR MET MET LYS GLU ASN PHE SEQRES 4 A 100 PRO ASN PHE LEU SER ALA CYS ASP LYS LYS GLY THR ASN SEQRES 5 A 100 TYR LEU ALA ASP VAL PHE GLU LYS LYS ASP LYS ASN GLU SEQRES 6 A 100 ASP LYS LYS ILE ASP PHE SER GLU PHE LEU SER LEU LEU SEQRES 7 A 100 GLY ASP ILE ALA THR ASP TYR HIS LYS GLN SER HIS GLY SEQRES 8 A 100 ALA ALA PRO CYS SER GLY GLY SER GLN SEQRES 1 B 100 SER ASN THR GLN ALA GLU ARG SER ILE ILE GLY MET ILE SEQRES 2 B 100 ASP MET PHE HIS LYS TYR THR ARG ARG ASP ASP LYS ILE SEQRES 3 B 100 ASP LYS PRO SER LEU LEU THR MET MET LYS GLU ASN PHE SEQRES 4 B 100 PRO ASN PHE LEU SER ALA CYS ASP LYS LYS GLY THR ASN SEQRES 5 B 100 TYR LEU ALA ASP VAL PHE GLU LYS LYS ASP LYS ASN GLU SEQRES 6 B 100 ASP LYS LYS ILE ASP PHE SER GLU PHE LEU SER LEU LEU SEQRES 7 B 100 GLY ASP ILE ALA THR ASP TYR HIS LYS GLN SER HIS GLY SEQRES 8 B 100 ALA ALA PRO CYS SER GLY GLY SER GLN
HET CA A 102 1 HET ZN A 103 1 HET CA B 102 1
HETNAM CA CALCIUM ION HETNAM ZN ZINC ION
FORMUL 3 CA 2(CA 2+) FORMUL 4 ZN ZN 2+ FORMUL 6 HOH *70(H2 O)
HELIX 1 A1 GLN A 4 LYS A 18 1 15 HELIX 2 A2 LYS A 28 PHE A 39 1 12 HELIX 3 A2' ASN A 41 LYS A 48 1 8 HELIX 4 A3 TYR A 53 LYS A 61 1 9 HELIX 5 A4 PHE A 71 HIS A 90 1 20 HELIX 6 B1 GLN B 4 LYS B 18 1 15 HELIX 7 B2 LYS B 28 PHE B 39 1 12 HELIX 8 B2' ASN B 41 LYS B 48 1 8 HELIX 9 B3 TYR B 53 LYS B 61 1 9 HELIX 10 B4 PHE B 71 HIS B 90 1 20
SSBOND 1 CYS A 46 CYS A 95 1555 1555 1.89 SSBOND 2 CYS B 46 CYS B 95 1555 1555 2.03
LINK CA CA A 102 OD1 ASP A 62 1555 1555 1.99 LINK CA CA A 102 OD1 ASN A 64 1555 1555 2.24 LINK CA CA A 102 OD1 ASP A 66 1555 1555 2.12 LINK CA CA A 102 O LYS A 68 1555 1555 2.23 LINK CA CA A 102 OE1 GLU A 73 1555 1555 2.48 LINK CA CA A 102 OE2 GLU A 73 1555 1555 2.47 LINK CA CA A 102 O HOH A 269 1555 1555 2.31 LINK ZN ZN A 103 NE2 HIS A 17 1555 1555 2.00 LINK ZN ZN A 103 OD1 ASP A 24 1555 1555 2.04 LINK ZN ZN A 103 OD2 ASP A 24 1555 1555 2.13 LINK ZN ZN A 103 NE2 HIS B 86 1555 1555 2.37 LINK ZN ZN A 103 NE2 HIS B 90 1555 1555 2.23 LINK CA CA B 102 OD1 ASP B 62 1555 1555 1.90 LINK CA CA B 102 OD1 ASN B 64 1555 1555 2.18 LINK CA CA B 102 OD1 ASP B 66 1555 1555 2.04 LINK CA CA B 102 O LYS B 68 1555 1555 2.26 LINK CA CA B 102 OE1 GLU B 73 1555 1555 2.63 LINK CA CA B 102 OE2 GLU B 73 1555 1555 2.52 LINK CA CA B 102 O HOH B 270 1555 1555 2.02 LINK CA CA A 102 OD2 ASP A 66 1555 1555 3.30 LINK CA CA B 102 OD2 ASP B 66 1555 1555 3.28
SITE 1 CAA 5 ASP A 62 ASN A 64 ASP A 66 LYS A 68 SITE 2 CAA 5 GLU A 73 SITE 1 CAB 5 ASP B 62 ASN B 64 ASP B 66 LYS A 68 SITE 2 CAB 5 GLU B 73 SITE 1 ZNA 4 HIS A 17 ASP A 24 HIS B 86 HIS B 90 SITE 1 AC1 6 ASP A 62 ASN A 64 ASP A 66 LYS A 68 SITE 2 AC1 6 GLU A 73 HOH A 269 SITE 1 AC2 4 HIS A 17 ASP A 24 HIS B 86 HIS B 90 SITE 1 AC3 6 ASP B 62 ASN B 64 ASP B 66 LYS B 68 SITE 2 AC3 6 GLU B 73 HOH B 270
CRYST1 52.150 56.670 76.380 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.019175 0.000000 0.000000 0.00000
SCALE2 0.000000 0.017646 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013092 0.00000
MTRIX1 1 0.159700 0.931400 0.327200 -17.58480 1
MTRIX2 1 0.926900 -0.255600 0.275000 8.48140 1
MTRIX3 1 0.339700 0.259300 -0.904100 38.33920 1